Newsroom
Newsroom
Industry News
In the current age of life sciences, we have come to invent better and better drugs that are increasingly efficient in relieving pain and treating...
Industry News
In the Future of Everything radio show, Stanford bioengineers Russ Altman and Christina Smolke discuss advances in synthetic biology and the rise of opioids made...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support of lead researcher Shugeng Cao,...
Blog Posts
Synthetic biology seems like a brand-new, precision scientific field – just bursting with potential – but is it really all that new? Biology is often...
Industry News
While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth....
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer....
Blog Posts
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s...
Blog Posts
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. Pucel joins the company...
Industry News
In the current age of life sciences, we have come to invent better and better drugs that are increasingly efficient in relieving pain and treating...
Industry News
In the Future of Everything radio show, Stanford bioengineers Russ Altman and Christina Smolke discuss advances in synthetic biology and the rise of opioids made...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...